Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
PUT
Ares Capital
ARCC
$14.3B
| $9.7M | ﹤0.01% |
625,700
-98,200
| -14% | -$1.51M |
|
1552
CALL
Trinity Industries
TRN
$2.38B
| $9.67M | ﹤0.01% |
555,600
+269,605
| +94% | +$4.44M |
|
|
ELLI
1553
PUT
DELISTED
Ellie Mae Inc
ELLI
| $9.63M | ﹤0.01% |
91,500
-18,600
| -17% | -$1.8M |
|
1554
CALL
SFL Corp
SFL
$1.61B
| $9.63M | ﹤0.01% |
654,000
-94,100
| -13% | -$1.41M |
|
1555
PUT
Genworth Financial
GNW
$3.74B
| $9.63M | ﹤0.01% |
1,941,300
+526,100
| +37% | +$2.02M |
|
1556
Herbalife
HLF
$1.33B
| $9.62M | ﹤0.01% |
310,370
-898,858
| -74% | -$28.4M |
|
|
SNI
1557
CALL
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
| $9.62M | ﹤0.01% |
151,500
+74,500
| +97% | +$4.77M |
|
1558
PUT
Vail Resorts
MTN
$5.24B
| $9.62M | ﹤0.01% |
61,300
+25,300
| +70% | +$3.86M |
|
|
SAVE
1559
CALL
DELISTED
Spirit Airlines, Inc.
SAVE
| $9.58M | ﹤0.01% |
225,200
+24,500
| +12% | +$1.02M |
|
1560
Opko Health
OPK
$1.11B
| $9.57M | ﹤0.01% |
904,154
-465,849
| -34% | -$4.64M |
|
1561
PUT
State Street SPDR S&P Dividend ETF
SDY
$22.2B
| $9.57M | ﹤0.01% |
113,500
+66,000
| +139% | +$5.63M |
|
1562
PUT
Bunge Global
BG
$21.7B
| $9.52M | ﹤0.01% |
160,800
-69,000
| -30% | -$4.29M |
|
|
ELLI
1563
CALL
DELISTED
Ellie Mae Inc
ELLI
| $9.52M | ﹤0.01% |
90,400
-60,700
| -40% | -$5.88M |
|
1564
PUT
State Street
STT
$53.3B
| $9.52M | ﹤0.01% |
136,700
+16,000
| +13% | +$1.05M |
|
1565
Acadia Pharmaceuticals
ACAD
$5.09B
| $9.5M | ﹤0.01% |
298,657
-181,346
| -38% | -$6.15M |
|
|
PPLI
1566
PUT
People Inc
PPLI
$2.93B
| $9.48M | ﹤0.01% |
848,823
+69,383
| +9% | +$732K |
|
|
AMSGP
1567
DELISTED
Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1
AMSGP
| $9.44M | ﹤0.01% |
74,400
| – | – |
|
|
TLRD
1568
CALL
DELISTED
Tailored Brands, Inc.
TLRD
| $9.43M | ﹤0.01% |
600,700
+178,300
| +42% | +$2.6M |
|
1569
PUT
Allegiant Air
ALGT
$2.28B
| $9.42M | ﹤0.01% |
71,300
+12,000
| +20% | +$1.63M |
|
1570
Aflac
AFL
$58.7B
| $9.41M | ﹤0.01% |
262,000
-6,802
| -3% | -$248K |
|
|
SFLY
1571
PUT
DELISTED
Shutterfly, Inc.
SFLY
| $9.41M | ﹤0.01% |
210,700
+204,000
| +3,045% | +$10.1M |
|
|
ENLK
1572
DELISTED
EnLink Midstream Partners, LP
ENLK
| $9.35M | ﹤0.01% |
527,956
+172,876
| +49% | +$3.03M |
|
1573
PUT
Hormel Foods
HRL
$13.1B
| $9.34M | ﹤0.01% |
246,300
+74,500
| +43% | +$2.77M |
|
|
DNKN
1574
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $9.32M | ﹤0.01% |
+178,951
| New | +$8.5M |
|
|
REN
1575
CALL
DELISTED
Resolute Energy Corporaton
REN
| $9.3M | ﹤0.01% |
+356,800
| New | +$5.13M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.99B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,278 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.